Mr. Peter Gibbs, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1900 W Park Dr, Suite 280, Westborough, MA 01581 Phone: 508-983-1400 |
News Archive
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
University of Pennsylvania School of Medicine researchers are recruiting healthy, HIV-negative adults to participate in a phase I clinical trial of an experimental HIV vaccine called PENNVAX-B, a DNA-based vaccine which is made using synthetic DNA-based HIV genes.
A US study on DNA-based and protein HIV vaccines has shown that an antibody and cellular immune response occurs within six weeks.
› Verified 9 days ago